Dafna D Gladman1,2, Yves Poulin3,4, Karen Adams3,4, Marc Bourcier3,4, Snezana Barac3,4, Kirk Barber3,4, Vinod Chandran3,4, Jan Dutz3,4, Cathy Flanagan3,4, Melinda J Gooderham3,4, Wayne P Gulliver3,4, Vincent C Ho3,4, Chih-Ho Hong3,4, Jacob Karsh3,4, Majed M Khraishi3,4, Charles W Lynde3,4, Kim A Papp3,4, Proton Rahman3,4, Sherry Rohekar3,4, Cheryl F Rosen3,4, Anthony S Russell3,4, Ronald B Vender3,4, Jensen Yeung3,4, Olga Ziouzina3,4, Michel Zummer3,4. 1. From the University of Toronto, Toronto, Ontario; Université Laval, Quebec, Quebec; Queen's University, Kingston; University of Ottawa, Ottawa; Western University, London; Dermatrials Research, Inc., Hamilton, Ontario; Université de Montréal, Montreal; Université de Sherbrooke, Sherbrooke, Quebec; The Winnipeg Clinic, Winnipeg, Manitoba; University of Calgary, Calgary; University of Alberta, Edmonton, Alberta; University of British Columbia, Vancouver, British Columbia; Memorial University of Newfoundland, St. John's, Newfoundland, Canada. dafna.gladman@utoronto.ca. 2. D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto; Y. Poulin, MD, Université Laval; K. Adams, MD, Université Laval; M. Bourcier, MD, Université de Sherbrooke; S. Barac, MD, The Winnipeg Clinic; K. Barber, MD, University of Calgary; V. Chandran, MBBS, MD, DM, PhD, University of Toronto; J. Dutz, MD, University of British Columbia; C. Flanagan, MD, University of British Columbia; M.J. Gooderham, MD, Queen's University; W.P. Gulliver, MD, Memorial University of Newfoundland; V.C. Ho, MD, University of British Columbia; C.H. Hong, MD, University of British Columbia; J. Karsh, MD, University of Ottawa; M.M. Khraishi, MBBCH, Memorial University of Newfoundland; C.W. Lynde, MD, University of Toronto; K.A. Papp, MD, PhD, University of Toronto; P. Rahman, MD, Memorial University of Newfoundland; S. Rohekar, MD, Western University; C.F. Rosen, MD, University of Toronto; A.S. Russell, MD, University of Alberta; R.B. Vender, MD, Dermatrials Research, Inc.; J. Yeung, MD, University of Toronto; O. Ziouzina, MD, University of Calgary; M. Zummer, MD, Université de Montréal. dafna.gladman@utoronto.ca. 3. From the University of Toronto, Toronto, Ontario; Université Laval, Quebec, Quebec; Queen's University, Kingston; University of Ottawa, Ottawa; Western University, London; Dermatrials Research, Inc., Hamilton, Ontario; Université de Montréal, Montreal; Université de Sherbrooke, Sherbrooke, Quebec; The Winnipeg Clinic, Winnipeg, Manitoba; University of Calgary, Calgary; University of Alberta, Edmonton, Alberta; University of British Columbia, Vancouver, British Columbia; Memorial University of Newfoundland, St. John's, Newfoundland, Canada. 4. D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto; Y. Poulin, MD, Université Laval; K. Adams, MD, Université Laval; M. Bourcier, MD, Université de Sherbrooke; S. Barac, MD, The Winnipeg Clinic; K. Barber, MD, University of Calgary; V. Chandran, MBBS, MD, DM, PhD, University of Toronto; J. Dutz, MD, University of British Columbia; C. Flanagan, MD, University of British Columbia; M.J. Gooderham, MD, Queen's University; W.P. Gulliver, MD, Memorial University of Newfoundland; V.C. Ho, MD, University of British Columbia; C.H. Hong, MD, University of British Columbia; J. Karsh, MD, University of Ottawa; M.M. Khraishi, MBBCH, Memorial University of Newfoundland; C.W. Lynde, MD, University of Toronto; K.A. Papp, MD, PhD, University of Toronto; P. Rahman, MD, Memorial University of Newfoundland; S. Rohekar, MD, Western University; C.F. Rosen, MD, University of Toronto; A.S. Russell, MD, University of Alberta; R.B. Vender, MD, Dermatrials Research, Inc.; J. Yeung, MD, University of Toronto; O. Ziouzina, MD, University of Calgary; M. Zummer, MD, Université de Montréal.
Abstract
OBJECTIVE: To develop preliminary treat-to-target (T2T) recommendations for psoriasis and psoriatic arthritis (PsA) for Canadian daily practice. METHODS: A task force composed of expert Canadian dermatologists and rheumatologists performed a needs assessment among Canadian clinicians treating these diseases as well as an extensive literature search on the outcome measures used in clinical trials and practice. RESULTS: Based on results from the needs assessment and literature search, the task force established 5 overarching principles and developed 8 preliminary T2T recommendations. CONCLUSION: The proposed recommendations should improve management of psoriasis and PsA in Canadian daily practice. However, these recommendations must be further validated in a real-world observational study to ensure that their use leads to better longterm outcomes.
OBJECTIVE: To develop preliminary treat-to-target (T2T) recommendations for psoriasis and psoriatic arthritis (PsA) for Canadian daily practice. METHODS: A task force composed of expert Canadian dermatologists and rheumatologists performed a needs assessment among Canadian clinicians treating these diseases as well as an extensive literature search on the outcome measures used in clinical trials and practice. RESULTS: Based on results from the needs assessment and literature search, the task force established 5 overarching principles and developed 8 preliminary T2T recommendations. CONCLUSION: The proposed recommendations should improve management of psoriasis and PsA in Canadian daily practice. However, these recommendations must be further validated in a real-world observational study to ensure that their use leads to better longterm outcomes.
Authors: R Bissonnette; T Luger; D Thaçi; D Toth; A Lacombe; S Xia; R Mazur; M Patekar; P Charef; M Milutinovic; C Leonardi; U Mrowietz Journal: J Eur Acad Dermatol Venereol Date: 2018-03-22 Impact factor: 6.166
Authors: Paolo Gisondi; Marina Talamonti; Andrea Chiricozzi; Stefano Piaserico; Paolo Amerio; Anna Balato; Federico Bardazzi; Piergiacomo Calzavara Pinton; Anna Campanati; Angelo Cattaneo; Paolo Dapavo; Clara De Simone; Valentina Dini; Maria C Fargnoli; Maria L Flori; Marco Galluzzo; Claudio Guarneri; Claudia Lasagni; Francesco Loconsole; Ada Lo Schiavo; Piergiorgio Malagoli; Giovanna Malara; Santo R Mercuri; Maria L Musumeci; Luigi Naldi; Manuela Papini; Aurora Parodi; Concetta Potenza; Francesca Prignano; Franco Rongioletti; Luca Stingeni; Rossana Tiberio; Marina Venturini; Luca Bianchi; Antonio Costanzo; Francesco Cusano; Giampiero Girolomoni; Anna M Offidani; Ketty Peris Journal: Dermatol Ther (Heidelb) Date: 2021-01-11
Authors: Jerry Bagel; John Nia; Peter W Hashim; Manmath Patekar; Ana de Vera; Sophie Hugot; Kuan Sheng; Summer Xia; Isabelle Gilloteau; Elisa Muscianisi; Andrew Blauvelt; Mark Lebwohl Journal: Dermatol Ther (Heidelb) Date: 2018-10-17